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Abstract:
Background:  Although  occipital  neuralgia  is  usually  caused  by  degenerative  arthropathy, nearly 20 other aetiologies 
may lead to this condition.
Methods:  We  present  the  first  case  report  of   hypertrophic  pachymeningitis  revealed  by isolated occipital neuralgia.
Results and conclusions:  Idiopathic  hypertrophic  pachymeningitis  is a plausible  cause  of  occipital neuralgia and may 
present without cranial-nerve palsy. There is no consensus on the treatment  for  idiopathic  hypertrophic  pachymeningitis, 
but  the  usual  approach  is to start corticotherapy and then to add immunosuppressants. When occipital neuralgia is not 
clinically isolated or when a first-line treatment fails, another disease diagnosis should be considered. However, the cost ef-
fectiveness of  extended investigations needs to be considered.
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Case report
A 56-year-old man was admitted with moderate-inten-
sity pain that originated at the base of  the skull and 
radiated  to the left side of  the occipital  scalp.  Left 
occipital neuralgia  was diagnosed.  A  few  weeks  lat-
er,  the  patient  was  admitted  again,  this  time  for 
an  intense headache that required opioid painkillers. 
Magnetic-resonance imaging (MRI) and computed to-
mography  (CT) scans showed thickening  of  the dura 
mater, ranging from the cerebellar tentorium (see arrow, 
Figure 1) to the meninges of  the second cervical verte-
bra (see arrow, Figure 2). 
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Figure 1: MRI T1 axial image showing thickening of  the left cerebellar tentorium.
Figure 2: CT-scan axial image showing thickening of  the meninges between the C1–C2 vertebrae.
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MRI excluded cerebral venous sinus thrombosis.
Cerebrospinal-fluid   analysis  (CSF)  showed  hyperpro-
teinorachia   (0.86  g/L)  with  normal glycorrhachia, 64 
leukocytes/mm3  with 93% activated non-clonal lym-
phocytes, mostly CD4+.
A   PCR assay to detect Mycobacterium tuberculosis 
DNA was negative. An examination and culture  of   the 
CSF  was  negative  which  allowed  eliminating  bac-
terial  causes,  especially tuberculosis. There were no 
abnormal cells in the CSF. Serological testing for HIV 1 
and 2 was negative. A body CT scan revealed no carci-
noma or other disease except for the cerebral anomaly 
(described  above).  We  did not  find any evidence  of  
lymphomatous  or systemic disorders (granulomatosis 
with polyangiitis, Sjögren's syndrome, rheumatoid ar-
thritis, mixed connective-tissue disease).  Therefore,  a 
meningeal  biopsy  was  performed  and  revealed lym-
phoplasmocytic infiltration with no abnormal cells. Ac-
cordingly, we diagnosed idiopathic hypertrophic cranial 
pachymeningitis (IHP).
During our investigations, a nerve block was performed 
to reduce the pain, and was repeated, but  the results 
were insufficient.  Slight asymmetry  in the muscles of  
the neck suggested damage to the 12th left cranial nerve. 
After this diagnosis, we initiated corticosteroid therapy.
However,  the patient  was  still  cortico-dependent  (at 
15  mg/day)  at 2 years  after  starting therapy.  Conse-
quently,  we  decided  to  introduce  cyclophosphamide 
therapy.  The  patient received six pulses of  cyclophos-
phamide at 0.7 g/m2 per month. A  MRI scan then 
showed significant   improvement,   in   particular   next 
to   the   median   parietal   cortex.
Cyclophosphamide  therapy was followed by a mainte-
nance  treatment. Our patient remains clinically stable 
under methotrexate therapy (17.5 mg/week and pred-
nisone 5mg/day). The patient no longer needs pain kill-
ers.
Discussion
Although   occipital   neuralgia   is   relatively   common 
and   is   predominantly   caused   by osteoarthritis,  the 
literature  provides  no formal  evidence  on its preva-
lence  and incidence, probably because of  its frequent 
ambulatory management1. Its diagnosis is based on cri-
teria from  the  current  International  Classification 
of   Headache  Disorder-2  (ICHD-2)2.  The principal 
causes of  occipital neuralgia are summarized in Table 1. 
A clinical examination, a complete blood count, sedi-
mentation rate, C-reactive protein, viral and bacterio-
logical  tests  and/or serologies,  in addition to imagery 
from a CT-scan or MRI, are required to exclude most 
secondary causes.
Hypertrophic  pachymeningitis  (HP) is a rare entity. 
Yonekawa et al.3 reported that 159 cases  were  found 
during  a  nationwide  survey  in  Japan  between  2005 
and  2009,  which included 70 cases of  idiopathic hyper-
trophic pachymeningitis. The causes of  HP are various:
infections, autoimmune disease, tumours, trauma,  or 
idiopathic.  Considering only IHP, in Yonekawa et 
al.'s study, females were predominant (gender ratio of  
1/0.75). The overall mean age was 54.8 +/- 16.5 years. 
Headache (62.9%) was the most common symptom 
and was often accompanied  by cranial-nerve  palsy 
(55.7%).  Corticotherapy  alone was effective  in 58.7% 
of  cases. Immunosuppressants  were added when there 
was a suboptimal response to corticosteroids:  this led 
to remission in 21.4% of  these cases. Bosman et al.4 
reported similar proportions when they reviewed treat-
ment of  IHP cases published between 1990 and 2008. 
They identified  60 patients: 93% were given a cortico-
therapy,  of  which 65% were monotherapies: this led 
to 46% relapse rate. Some patients required radiothera-
py or surgery when their condition became too serious 
(e.g., hydrocephalus).
Herein,  we  have  described,  for  the  first  time  to 
our  knowledge,  a  case  of   idiopathic pachymeningitis 
revealed by isolated occipital neuralgia. We found one 
similar case reported in the literature, but occipital neu-
ralgia was not isolated as the patient also presented with
tinnitus and deafness at admission. Corticosteroids did 
not improve the clinical situation and, similar to our pa-
tient, a sparing treatment had to be introduced5.
Conclusion
IHP is a possible cause of  occipital neuralgia and may 
present without cranial-nerve palsy at the beginning. 
There is no consensus on IHP treatment, but the most 
common approach is to initiate  corticotherapy  and 
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Table 1: The main etiologies of occipital neuralgia 
 
Causes Personal history Clinical symptoms Biological tests Imaging 
Vascular compression 
[6]: occipital artery, 
ectatic vertebral 






Vasculitis [7]: giant- 
cell arteritis 







reduction of the 


















Vascular bruit None MRI 
Pott’s disease [9] Personal history 
of tuberculosis or 
contact with 
tuberculosis 
Back pain, fever, 
night sweats, 
anorexia, weight 
loss, spinal mass, 
paresthesia, or 





skin test, bone 
biopsy 
MRI, X-ray of 
the spine, CT- 
scanner 
















loss of bowel or 
bladder function or 



























History of a recent 
facial herpes 
lesion 
Reddening of the 
occipital skin with 
vesicles 
Herpes viral 
culture of a 






   IgG and IgM)  
Joint and bone 
diseases [12]: 
hypermobile posterior 
arch of atlas, 
osteolytic lesion of 
unknown cause, or 
exuberant callus 
formation 






















X-ray of the 
hands; MRI 
Tumor [15] Personal history 












Abbreviations: CRP: C-reactive protein; PMR: polymyalgia rheumatica; MRI: magnetic resonance imaging; VDRL: 
Venereal Disease Research Laboratory; RPR: rapid plasma reagin; TPHA: Treponema pallidum hemagglutination 
assay. 
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then  to  add  immunosuppressants.  We  suggest  that 
additional exploration of  occipital neuralgia is warrant-
ed when conventional treatments fail. However, the 
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